Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620

Untch M, Loibl S, Fasching P (2019)

Publication Type: Journal article, Letter

Publication year: 2019

Journal

Breast Care Karger

DOI: 10.1159/000500624

Authors with CRIS profile

Peter Fasching Professur für Translationale Frauenheilkunde und Geburtshilfe

Involved external institutions

GBG Forschungs GmbH (German Breast Group) DE Germany (DE) HELIOS Kliniken DE Germany (DE)

How to cite

APA:

Untch, M., Loibl, S., & Fasching, P. (2019). Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620. Breast Care. https://doi.org/10.1159/000500624

MLA:

Untch, Michael, Sibylle Loibl, and Peter Fasching. "Concerning Dediu M, Zielinski A: A Proposal to Redefine Pathologic Complete Remission as Endpoint following Neoadjuvant Chemotherapy in Early Breast Cancer. Breast Care 2019; Doi 10.1159/000500620." Breast Care (2019).

BibTeX: Download